glp-1 for lipedema Medications and | What Women Need to Know GLP-1 RAs in Lipedema: Insights

report any vision changes to your provider

However, like all medications, they may be associated with certain side effects, such as gastrointestinal issues, including nausea, vomiting, diarrhea, and constipation

Weight loss and physical activity changes: Patients achieving significant weight loss with GLP-1 therapy may experience changes in exercise tolerance and breathing patterns

Our GLP-1 supplement support products are recommended by healthcare professionals and trusted by a broad spectrum of users

Sourcing note: All patient names, testimonials, and outcome figures in this section are reproduced from Sunlight's publicly published website and marketing materials

In August 2025, SC Wegovy became the first GLP-1 to be approved for metabolic dysfunction-associated steatohepatitis (MASH)